Amy Berger
Overview
Explore the profile of Amy Berger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
742
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Roldan E, Tsai R, Berger A, Franco-Macias E
J Alzheimers Dis Rep
. 2024 May;
8(1):709-713.
PMID: 38746633
A 60-year-old man presented to a Neurology Clinic specialized in cognitive disorders to evaluate memory complaints. A comprehensive neuropsychological examination detected an isolated and severe hippocampal memory deficit. Laboratory tests,...
2.
Greenwald H, Berger A, Wilson R, Greenwald D, Lannon E, Johnson-Smith P, et al.
Am J Addict
. 2024 Mar;
33(4):423-429.
PMID: 38430207
Background And Objectives: While inpatient withdrawal management/acute stabilization can improve outcomes for individuals with opioid use disorder (OUD), patients often leave treatment early due to mood, tension, and cravings associated...
3.
Hsiao-Nakamoto J, Chiu C, VandeVrede L, Ravi R, Vandenberg B, De Groot J, et al.
bioRxiv
. 2024 Feb;
PMID: 38405775
Background: Frontotemporal dementia (FTD) is the most common cause of early-onset dementia with 10-20% of cases caused by mutations in one of three genes: , , or . To effectively...
4.
Leng K, Cadwell C, Devine W, Tihan T, Qi Z, Singhal N, et al.
bioRxiv
. 2024 Feb;
PMID: 38328093
Introduction: Mosaic gain of chromosome 1q (chr1q) has been associated with malformation of cortical development (MCD) and epilepsy. Hyaline protoplasmic astrocytopathy (HPA) is a rare neuropathological finding seen in cases...
5.
Wilens T, Stone M, Lanni S, Berger A, Wilson R, Lydston M, et al.
J Atten Disord
. 2024 Jan;
28(5):751-790.
PMID: 38178649
Introduction: Executive function (EF) deficits are common in youth with ADHD and pose significant functional impairments. The extent and effect of interventions addressing EF in youth with ADHD remain unclear....
6.
Rolfes M, Harroud A, Zorn K, Tubati A, Omura C, Kurtz K, et al.
Neurol Neuroimmunol Neuroinflamm
. 2023 Jun;
10(5).
PMID: 37339889
Mutations in the complement factor I () gene have previously been identified as causes of recurrent CNS inflammation. We present a case of a 26-year-old man with 18 episodes of...
7.
McKowen J, Berger A, Towbin J, Yule A, Woodward D, Nowinski L, et al.
Case Rep Psychiatry
. 2023 Apr;
2023:8998160.
PMID: 37038552
Research highlights the increasing overlap of autism spectrum disorder and substance use disorders in young people. However, no behavioral treatments exist addressing this comorbidity despite great need. A team of...
8.
Woodward D, Wilens T, Yule A, DiSalvo M, Taubin D, Berger A, et al.
J Affect Disord
. 2023 Mar;
329:300-306.
PMID: 36863464
Background: Conduct Disorder (CD) is highly comorbid with Bipolar Disorder (BP) and this comorbidity is associated with high morbidity and dysfunction. We sought to better understand the clinical characteristics and...
9.
Woo Hong P, Santana J, Larson S, Berger A, Mustafa M, Taylor J, et al.
J Pediatr Surg
. 2022 Nov;
58(1):106-110.
PMID: 36335011
Purpose: Child physical abuse (CPA) is closely linked to social factors like insurance status with limited evaluation at a structural population-level. This study evaluates the role of social determinants of...
10.
Taubin D, Berger A, Greenwald D, Greenwald H, Burke C, Gongora D, et al.
Am J Addict
. 2022 Sep;
32(1):13-23.
PMID: 36128667
Background And Objectives: Virtual reality (VR) therapy may be an effective tool in treating urges and cravings in substance use disorder (SUD). Given the high co-occurrence of difficulties with mood,...